Creatinine (Cr)

Creatinine is a nitrogenous organic acid produced from the non-enzymatic breakdown of creatine and phosphocreatine in muscle tissue. It is produced at a relatively constant rate proportional to muscle mass and is released into the blood, where it is primarily cleared by the kidneys via glomerular filtration, with a small percentage (approx. 10-20%) undergoing active tubular secretion [PubChem, CID 588; StatPearls, 'Creatinine']. Because it is not significantly reabsorbed or metabolized by the kidneys, serum creatinine serves as the most widely used clinical biomarker for estimating the glomerular filtration rate (GFR) and monitoring kidney health [NIH, 'Creatinine Test']. While creatinine is not a drug target, it is essential for calculating the correct dosage of medications with narrow therapeutic windows that are renally excreted. Many drugs can pharmacologically interfere with creatinine secretion by inhibiting transporters such as Organic Cation Transporter 2 (OCT2) or Multidrug and Toxin Extrusion 1 (MATE1), which can lead to clinically significant but non-pathological elevations in serum levels [PubMed, PMID: 32305545]. Therefore, understanding the baseline and variations in creatinine is vital for biotech analysts and clinicians to assess drug safety and renal toxicity profile accurately.

Other names

1-methylglycocyamidine2-amino-1-methyl-2-imidazolin-4-one2-amino-1-methyl-5H-imidazol-4-one

Creatinine is not a therapeutic target but a metabolic waste product. Drugs interacting with its levels typically do so by inhibiting the renal transporters (e.g., OCT2, MATE1) responsible for its tubular secretion, which can lead to an increase in serum creatinine levels without a corresponding decrease in glomerular filtration [PubMed, PMID: 24515502].